The current state of GMO governance: Are we ready for GM animals?

Biotechnology Advances

Volumn 30, Issue 6, 2012, Pages 1336-1343

  Vàzquez Salat, Núria ^a   Salter, Brian ^a   Smets, Greet ^b   Houdebine, Louis Marie ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Perseus BVBA   (Belgium)

^c INRA Institut National de la Recherche Agronomique   (France)

Author keywords

EU; Genetically modified; GM animal; GMO; Governance; Green biotechnology; Red biotechnology; Regulation; USA

Indexed keywords

GENETICALLY MODIFIED; GMO; GOVERNANCE; REGULATION; USA;

BIOTECHNOLOGY; EUROPIUM;

ANIMALS;

ANIMAL; BIOTECHNOLOGY; COMMERCIALIZATION; CULTURAL LANDSCAPE; EUROPEAN UNION; FUTURE PROSPECT; GENETICALLY MODIFIED ORGANISM; REGULATORY APPROACH;

ANIMAL; BIOTECHNOLOGY; EUROPEAN UNION; GROWTH, DEVELOPMENT AND AGING; INTERNATIONAL COOPERATION; REVIEW; SOCIAL CONTROL; TRANSGENIC ORGANISM; UNITED STATES;

ANIMALS; BIOTECHNOLOGY; EUROPEAN UNION; INTERNATIONALITY; ORGANISMS, GENETICALLY MODIFIED; SOCIAL CONTROL, FORMAL; UNITED STATES;

UNITED STATES;

ANIMALIA;

EID: 84867722825     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2012.02.006     Document Type: Review

References (16)

1. Bagchi-Sen S., Scully J. Strategies and external relationships of small and medium-sized enterprises in the US agricultural biotechnology sector. Environ Plann C 2007, 25:844-860.
2. Fox J.L. FDA transgenic animal guidance finally surfaces. Nat Biotechnol 2008, 26:1205-1207.
3. Hobson-West P. Beasts and boundaries: an introduction to animals in sociology, science and society. Qual Sociol Rev 2007, 3(1):23-41.
4. Houdebine L.M. Meeting report: UC Davis Transgenic Animal Research Conference VII. Tahoe City, USA. Transgenic Res 2010, 19:127-130.
5. James C. Global Status of Commercialized Biotech/GM Crops: 2009. ISAAA Brief 2009, no. 41. ISAAA, Ithaca, NY.
6. Kling J. First US approval for a transgenic animal drug. Nat Biotechnol 2009, 27:302-304.
7. Laible G. Enhancing livestock through genetic engineering-recent advances and future prospects. Comp Immunol Microbiol Infect Dis 2009, 32:123-137.
8. Miller H.I. FDA on transgenic animals-a dog's breakfast?. Nat Biotechnol 2008, 26:159-160.
9. Pascoe R. Herman the bull gets Dutch go ahead. Br Med J 1994, 309:148-149.
10. Potier M., Tebar Less C. Trade and environment at the OECD: Key issues since 1991. Working Paper on Trade and Environment, No. 2008-01 2008, Organisation for Economic Co-operation and Development, 41pp.
11. Prakash A., Kollman K.L. Biopolitics in the EU and the US: a race to the bottom or convergence to the top?. Int Stud Q 2003, 47:617-641.
12. Schmidt C. Belated approval of first recombinant protein from animal. Nat Biotechnol 2006, 24:877.
13. Skogstad G. Legitimacy and/or policy effectiveness? Network governance and GMO regulation in the European Union. J Eur Public Policy 2003, 10(3):321-338.
14. Vàzquez-Salat N., Salter B. Policy implications of introducing genetically modified animals in the European Union. PEGASUS Deliverable 6.2 2011, October. http://www.pegasus.wur.nl/UK/.
15. Zhang X.Y., Huang J.K., Qiu H.G., Huang Z.R. A consumer segmentation study with regards to genetically modified food in urban China. Food Policy 2010, 35:456-462.
16. Zika E., Papatryfon I., Wolf O., Gómez-Barbero M., Stein A.J., Bock A. Consequences, Opportunities and Challenges of Modern Biotechnology for Europe. Joint Research Centre of the European Commission, EUR 23413 EN 2007, European Communities, Luxemburg, 235pp.